Document:

Form of Restricted Stock Agreement

 Exhibit 10.10 
 We are pleased to inform you that on                      (the
“Grant Date”), pursuant to the Unigene Laboratories, Inc. 2006 Stock-Based Incentive Compensation Plan (the “Plan”), the Compensation Committee of the Board of Directors (the “Committee”) of Unigene Laboratories, Inc.
(the “Company”) granted you              shares of the Company’s common stock, par value $0.01, (hereinafter either the “Restricted Stock” or “Award”),
subject to the restrictions set forth below. 
 This Award is subject to the applicable terms and conditions of the Plan, which are incorporated herein by
reference, and in the event of any contradiction, distinction or difference between this letter and the terms of the Plan, the terms of the Plan will control. Unless otherwise stated, all capitalized terms used herein have the meanings set forth in
the Plan. By accepting this Award you (i) acknowledge that you have received and read a copy of the Plan and understand its terms and (ii) acknowledge that with respect to this Award and the Restricted Stock, you are bound by the terms of
the Plan. 
 Subject to your continued employment with the Company the restrictions applicable to your Restricted Stock will lapse on
                    , the          anniversary of the Grant Date. Once vested, the Restricted Stock will be
transferable, without consideration, to immediate family members (i.e., children, grandchildren or spouse), to trusts for the benefit of such immediate family members and to partnerships in which such family members are the only partner. 

Should your employment with the Company terminate for any reason (including by reason of death or disability) before any portion of your Award vests, then that
portion of your Award shall be forfeited with no further compensation due to you. Finally, if you are terminated by the Company for Cause, your entire Award, regardless of whether any or all of the shares of Restricted Stock that relate to such
Award are vested, shall be forfeited with no further compensation due to you. 
 In the event that during your service with the Company, a Change in Control,
as defined in the Plan, occurs, your Award will vest in full. 
 When each portion of your Award vests, you must make appropriate arrangements with the
Company to provide for the withholding of the taxes that will be due with respect to this Award as it vests. As promptly thereafter as possible, the Company will issue to you, or if such certificates were previously issued, the Company will deliver
to you, certificates for your vested shares of Restricted Stock, designating you as the registered owner. Upon such receipt, you agree to deliver the certificate(s) together with a signed and undated stock power to the Company or the Company’s
designee authorizing the Committee to transfer title to the certificate(s) representing any shares of Restricted Stock that are forfeited under the terms of the Plan and this Award to the Company in the event that your employment with the Company
should terminate for Cause. 

 The construction and interpretation of any provision of this Award or the Plan shall be final and conclusive when made by
the Committee. 
 Nothing in this letter shall confer on you the right to continue in the service of the Company or interfere in any way with the right of
the Company to terminate your service at any time. 
 You should sign and return a copy of this agreement to the Vice President of Finance indicating your
agreement to the terms of this letter and the Award granted hereby. This acknowledgement must be returned within fifteen (15) days; otherwise, the Award will lapse and become null and void. Your signature will also acknowledge that this letter
reflects our final agreement regarding the Award granted hereunder and supersedes any prior written or oral agreement, understanding or communication otherwise regarding your Award, and that you have received and reviewed the Plan and that you agree
to abide by the applicable terms of these documents as provided herein. 
  

	
	Very truly yours,
	
	  

  

					
	The undersigned hereby agrees to the foregoing:
			
	  
	 		 	  

	Name	 		 	Date

  

 - 2 -Employment Agreement - Warren P. Levy

 Exhibit 10.12 
 FIRST AMENDMENT TO EMPLOYMENT AGREEMENT 
 THIS FIRST AMENDMENT to
the Employment Agreement, dated as of January 1, 2000 (the “Agreement”) is made as of this 22nd day of December, 2008 by and between UNIGENE LABORATORIES, INC. (the “Company”) and Warren Levy (the
“Executive”). 
 WHEREAS, the Company and the Executive desire to amend the Agreement to comply with the final regulations
issued under Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”); and 
 WHEREAS, capitalized
terms not otherwise defined herein shall have the meanings ascribed to them by the Agreement. 
 NOW, THEREFORE, the Company and the
Executive, intending to be legally bound, hereby amend the Agreement as follows, effective as of January 1, 2009: 
 1. Section 5
is hereby amended and restated to read in its entirety as follows: 
 “5. Business Expenses. The Company shall reimburse the
Executive, promptly upon presentation of itemized vouchers (but no later than December 31 of the year following the year during which such expense was incurred), for all ordinary and necessary business expenses incurred by the Executive in the
performance of his duties hereunder.” 
 2. Section 10 is hereby amended and restated to read in its entirety as follows:

 “10. Termination Without Cause. The Company may terminate the employment of the Executive without “cause” (as defined
in Section 9), subject to compliance with this Section 10. 
 (a) In the event the Executive’s employment is
terminated without cause, the Executive shall be entitled to: 
 (1) a severance payment consisting of: 
 (A) a lump-sum payment equal to the salary that the Executive would have earned for the remaining term of the Agreement, if the remaining
term (either the initial term or as extended) is more than one year; or 
 (B) a lump-sum payment equal to the
Executive’s then-current annual salary, if the remaining term of the Agreement (either the initial term or as extended) is one year or less, in each case payable as soon as practicable following the termination date, but no later than 90 days
thereafter; and 

 (2) a payment in cash equal to the cash value of all accrued vacation days, payable as
soon as practicable following the termination date, but no later than 90 days thereafter. 
 (b) Termination of employment
under this Section 10 shall not terminate the Executive’s obligations under Sections 7, 8 or 13.” 
 2. Section 11 is
hereby amended and restated to read in its entirety as follows: 
 “11. Resignation by the Executive for Good Reason. 

(a) The Executive may resign for good reason if one or both of the following occur: 
 (1) a Change of Control at Unigene (as defined in paragraph (d) below); or 
 (2) a material diminution in the Executive’s responsibilities without the Executive’s consent. 
 (b) In the event the Executive resigns for good reason, the Executive shall be entitled to: 
 (1) a severance payment consisting of: 
 (A) a lump-sum payment equal to the salary that the Executive would have earned for the remaining term of the Agreement, if the remaining term (either the initial term or as extended) is more than one year; or

 (B) a lump-sum payment equal to the Executive’s then-current annual salary, if the remaining term of the Agreement
(either the initial term or as extended) is one year or less, in each case payable as soon as practicable following the termination date, but no later than 90 days thereafter; and 
 (2) a payment in cash equal to the cash value of all accrued vacation days, payable as soon as practicable following the termination date,
but no later than 90 days thereafter. 
 (c) Termination of employment under this Section 11 shall not terminate the
Executive’s obligations under Sections 7, 8 or 13.” 
 3. Section 12 of the Agreement is hereby amended and restated to read
in its entirety as follows: 

 “12. Disability of the Executive. In the event that the Executive, during the period while
employed under this Agreement, incurs a “Disability” (as defined below), the Company may terminate the Executive’s employment under this Agreement. Upon the Executive’s Disability, the Executive shall be entitled to a lump sum
payment equal to the Executive’s then-current annual salary, payable as soon as practicable following the date of the Executive’s Disability, but no later than 90 days thereafter. Following such payment, the Company shall be relieved of
all further obligations hereunder. Termination of employment under this Section 12 shall not terminate the Executive’s obligations under Sections 7, 8 or 13. 
 For purposes of this Agreement, “Disability” shall mean that the Executive is (a) unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental
impairment which can be expected to result in death or can be expected to last for a continuous period of not less than twelve (12) months, or (b) by reason of any medically determinable physical or mental impairment which can be expected
to result in death or can be expected to last for a continuous period of not less than 12 months, receiving income replacement benefits for a period of not less than three months under an accident and health plan maintained by the Company.”

 4. A new Section 23 is hereby added to the Agreement, which shall read in its entirety as follows: 
 “23. Compliance with Code Section 409A. Notwithstanding anything in this Agreement to the contrary, if (i) the Executive is entitled
to receive payments under this Agreement by reason of his ‘separation from service’ (as such term is defined in Code Section 409A) other than as a result of his death, (ii) the Executive is a ‘specified employee’ within
the meaning of Code Section 409A for the period in which the payment under this Agreement would otherwise commence, and (iii) such payment would otherwise subject the Executive to any tax, interest or penalty imposed under Code
Section 409A (or any regulation promulgated thereunder) if the payment were to commence within six months of a termination of Executive’s employment, then such payment required under this Agreement shall not commence until the first normal
payroll date which is at least six months after the termination of Executive’s employment.” 
 5. Except as expressly amended
hereby, the Agreement shall remain unmodified and in full force and effect. 

 IN WITNESS WHEREOF, the parties have executed this First Amendment as of the day and year first above written.

  

			
	UNIGENE LABORATORIES, INC.
		
	By:	 	 /s/ William Steinhauer

			
	Printed Name:	 	 William Steinhauer

			
	Title:	 	 Vice President of Finance

	
	EXECUTIVE
	
	 /s/ Warren P. Levy

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00155-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00155-of-00352.parquet"}]]